Deltex Medical Group (DEMG)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.15p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.00p
  • 52 Week Low: 0.90p
  • Currency: UK Pounds
  • Shares Issued: 518.62m
  • Volume: 110,000
  • Market Cap: £5.96m
  • RiskGrade: 267
  • Beta: 0.34

Deltex makes 'significant reduction' in costs

By Iain Gilbert

Date: Friday 25 Jan 2019

LONDON (ShareCast) - (Sharecast News) - Doppler monitoring outfit Deltex Medical has seen a significant reduction in costs following the implementation of its new strategy.
Deltex said it was able to deliver "substantially improved profitability and cash generation" during the three months ended 31 December and now expects that it will be EBITDA positive in the new year.

While Deltex expected lower levels of revenues during the initial phase of the implementation as it switched its focus towards driving revenues from existing customers, the targeted approach offset much of those concerns as several other costs were able to be "significantly reduced".

Overall, the AIM-listed firm recorded revenues slightly behind expectations at approximately £5m, while full-year losses before exceptional items were expected to be "broadly in line with market expectations".

Gross cash was up 200% at £600,000.

Chairman Nigel Keen said: "The initial results from the new business strategy of building a more stable business as a result of improved profitability and cash generation are most encouraging; we are looking forward to seeing further progress during 2019."

As of 0840 GMT, Deltex shares had shot up 15.79% to 1.10p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DEMG Market Data

Currency UK Pounds
Share Price 1.15p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.00p
52 Week Low 0.90p
Volume 110,000
Shares Issued 518.62m
Market Cap £5.96m
Beta 0.34
RiskGrade 267

DEMG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.83% below the market average34.83% below the market average34.83% below the market average34.83% below the market average34.83% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Price Trend
55.91% below the market average55.91% below the market average55.91% below the market average55.91% below the market average55.91% below the market average
65% below the sector average65% below the sector average65% below the sector average65% below the sector average65% below the sector average
Income Not Available
Growth
55.07% below the market average55.07% below the market average55.07% below the market average55.07% below the market average55.07% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DEMG Dividends

No dividends found

Trades for 15-Nov-2019

Time Volume / Share Price
08:15 110,000 @ 1.18p

DEMG Key Personnel

Chair Nigel J Keen
Finance Director Jonathan David Shaw
CEO Andy Mears

Top of Page